These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3714778)

  • 21. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the central and peripheral effects of atropine on force lever performance.
    Preston KL; Schuster CR
    Pharmacol Biochem Behav; 1982 Mar; 16(3):423-7. PubMed ID: 7079278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in schedule-controlled response and schedule-induced drinking after cholinergic blockers in rats.
    Kuribara H; Tadokoro S
    Psychopharmacology (Berl); 1982; 76(3):251-4. PubMed ID: 6808545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM; Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats.
    Sharf R; Ranaldi R
    Psychopharmacology (Berl); 2006 Jan; 184(1):87-94. PubMed ID: 16307293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ; Smith CB
    Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat.
    Evenden J
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):381-90. PubMed ID: 12373438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampo-entorhinal area upon passive avoidance learning in young rats.
    Blozovski D; Hennocq N
    Psychopharmacology (Berl); 1982; 76(4):351-8. PubMed ID: 6812110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic involvement in the action of formetanate on operant behavior in rats.
    Moser VC; MacPhail RC
    Pharmacol Biochem Behav; 1987 Jan; 26(1):119-21. PubMed ID: 3562483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atropine- and scopolamine-resistant subtypes of muscarinic receptors in the rabbit aorta.
    Manjeet S; Sim MK
    Eur J Pharmacol; 1989 Dec; 174(1):99-105. PubMed ID: 2612581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic atropine administration on the rat urinary bladder.
    Levin RM; Ruggieri MR; Lee W; Wein AJ
    J Urol; 1988 Jun; 139(6):1347-9. PubMed ID: 3373612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance to the behavioral effects of scopolamine in rats.
    Charney NH; Reynolds GS
    Psychopharmacologia; 1967 Oct; 11(5):379-87. PubMed ID: 5587641
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum anticholinergic activity and behavior following atropine sulfate administration in the rat.
    O'Hare E; Weldon DT; Bettin K; Cleary J; Mach JR
    Pharmacol Biochem Behav; 1997 Jan; 56(1):151-4. PubMed ID: 8981623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centrally-mediated hyperalgesia in mice produced by the antimuscarinic agents atropine and hyoscine.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1981 Jun; 33(6):390-1. PubMed ID: 6115016
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of certain central effects of atropine, scopolamine and their quaternary ammonium derivatives in animals].
    Malatray J; Simon P
    Therapie; 1972; 27(1):153-66. PubMed ID: 5017551
    [No Abstract]   [Full Text] [Related]  

  • 38. Scopolamine prevents the development of sensitization to methamphetamine.
    Ohmori T; Abekawa T; Koyama T
    Life Sci; 1995; 56(14):1223-9. PubMed ID: 7475900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone potentiates scopolamine-induced disruptions of nonspatial learning in gonadectomized male rats.
    Leonard ST; Moerschbaecher JM; Winsauer PJ
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):48-57. PubMed ID: 17295584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.